BYRON BREEDING: Open Payments
NPI 1548241359 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,605 in 99 payments from 14 companies in 2025. Trend: 2023 $1,533 · 2024 $1,843 · 2025 $1,605
Food & beverage: $1,605
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $386 |
| PFIZER INC. | 17 | $262 |
| Novo Nordisk Inc | 13 | $211 |
| Amgen Inc. | 11 | $155 |
| Lilly USA, LLC | 5 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $72 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| ACADIA Pharmaceuticals Inc | 2 | $53 |
Products named: VRAYLAR, NURTEC ODT, OTEZLA, REXULTI, Ozempic, QULIPTA, CAPLYTA, Auvelity.
Industry payments across TN — which companies pay providers there.
